Gene therapy in development for deadly newborn lung disease

A gene therapy in development by researchers at The Ottawa Hospital, CHEO and uOttawa in collaboration with the University of Guelph, is showing dramatic results in mice with this disorder, improving their life expectancy from two days to over six months, according to...

New funding for gene therapy development at Xplore Lab

Xplore Lab and their collaborators at the University of Guelph have received a Canadian Institutes of Health Research project grant and a Collaborative Health Research Project grant to further develop an AAV vector expressing human SPB to test its potential as a...